Ad
Ad
Ad
Ad
Ad
Ad
© Almi Invest Business | September 28, 2021

Swedish semiconductor startup raises $1M seed capital

Almi Invest is investing close to SEK 3 million in AlixLabs, a company developing a new method for manufacturing semiconductor components cheaper and faster. Private investors, including NHL professionals Michael, Alexander and William Nylander, are also participating in the issue for a total of SEK 9 million (USD 1 million).

Today's semiconductor components are extremely small, and are becoming smaller still, making them increasingly more difficult and expensive to manufacture. The industry is working to cope with this challenge through new and innovative approaches. Common to these new methods is that they are complex and in most cases extremely expensive. Now AlixLabs from Lund, Sweden, has developed a new, innovative method for manufacturing semiconductor components with a high degree of packing, which eliminates several steps in the manufacturing process - Atomic Layer Etch Pitchsplitting (APS). The company claims in a press release that the method makes the components cheaper and less resource-intensive to manufacture and can open up a new path for a more sustainable mass production of electronics. The method is also said to make it possible to manufacture extremely small semiconductor components in an accurate and efficient way, which means that also smaller production facilities in, for example, Europe will be able to manufacture the components with manageable investments. Today, basically all production of leading edge semiconductors takes place in the USA and Asia, mainly in Taiwan and South Korea. The funds raised will be used for product development and validation of the company's APS-technology. "AlixLab's disruptive manufacturing method has enormous market potential and enables continued technology development and more powerful electronics that are at the same time much more resource-efficient," says Anna Gisselsson, Investment Manager at Almi Invest in the press release.The company's method is covered by an approved patent in the United States* and it has additional patent applications in other countries. "Thanks to this investment, we can take the company to the next level," adds Dr. Jonas Sundqvist, CEO of AlixLabs. Today, we have a number of ongoing negotiations with R&D actors, equipment and semiconductor manufacturers to create a basis for further cooperation for the development of our products. In the longer term, we want to create an ecosystem covering the complete value chain for APS and we hope to have a strong base in Europe with a global reach. "The R&D from these funds will allow us to strenghten and expand our IP portfolio for our properitary APS-technology," says Dr. Dmitry Suyatin, CTO of AlixLabs.
Ad
Ad
Load more news
October 14 2021 5:14 pm V18.25.1-2